Thrita

Published by: Kowsar

Histopathological Distribution of Ovarian Masses Occurring After Hysterectomy: A Five-Year Assay in Iranian Patients

Afsaneh Lalooei 1 , Seyedeh Razieh Hashemi 1 and Mohammad Hossein Khosravi 2 , *
Authors Information
1 Obstetrics and Gynecology Department, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Students’ Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Thrita: March 01, 2016, 5 (1); e33131
  • Published Online: January 30, 2016
  • Article Type: Brief Report
  • Received: September 13, 2015
  • Revised: October 14, 2015
  • Accepted: October 30, 2015
  • DOI: 10.5812/thrita.33131

To Cite: Lalooei A, Hashemi S R, Khosravi M H. Histopathological Distribution of Ovarian Masses Occurring After Hysterectomy: A Five-Year Assay in Iranian Patients, Thrita. 2016 ;5(1):e33131. doi: 10.5812/thrita.33131.

Abstract
Copyright © 2016, Thrita. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Bhatnagar P, Desai E, Patel U, Leuva B. Delayed re-laparotomy after total hysterectomy. Int J Reprod Contracept Obstet Gynecol. 2013; 2(1): 12-5
  • 2. Hosseini M, Masoumi Kashani N. Assessment serum LH, FSH/tumor fluid FSH, LH ratio in ovarian mass. Pejouhesh. 2010; 34(3): 182-6
  • 3. Runnebaum IB, Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol. 2001; 127(2): 73-9[DOI]
  • 4. McGowan L. Ovarian cancer after hysterectomy. Obstet Gynecol. 1987; 69(3 Pt 1): 386-9[PubMed]
  • 5. Loft A, Lidegaard O, Tabor A. Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up. BJOG. 1997; 104(11): 1296-301[DOI]
  • 6. Holub Z, Jandourek M, Jabor A, Kliment L, Wagnerova M. Does hysterectomy without salpingo-oophorectomy influence the reoperation rate for adnexal pathology? A retrospective study. Clin Exp Obstet Gynecol. 1999; 27(2): 109-12
  • 7. Plockinger B, Kolbl H. Development of ovarian pathology after hysterectomy without oophorectomy. J Am Coll Surg. 1994; 178(6): 581-5[PubMed]
  • 8. Chan JK, Urban R, Capra AM, Jacoby V, Osann K, Whittemore A, et al. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy. Obstet Gynecol. 2014; 123(1): 65-72[DOI][PubMed]
  • 9. Chiu Y, Chen C, Chiu L, Yen Y, Chang C, Tzeng C, et al. Occurrence of ovarian cancer 13 years after a total hysterectomy and bilateral salpingo-oophorectomy for endometriosis: A case report and literature review. GMIT. 2015; 4(1): 23-5[DOI]
  • 10. Vorwergk J, Radosa MP, Nicolaus K, Baus N, Jimenez Cruz J, Rengsberger M, et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: Complications and re-operation rate. J Cancer Res Clin Oncol. 2014; 140(5): 859-65[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments